Sen. Sanders launches probe of Novo's Wegovy and Ozempic pricing

Nicole DeFeudis

Editor

Sen. Bernie Sanders (I-VT) is ramping up his campaign against what he says are “outrageously high” list prices for Novo Nordisk’s weight loss and diabetes …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sen. Sanders launches probe of Novo's Wegovy and Ozempic pricing

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Sen. Sanders launch­es probe of Novo's We­govy and Ozem­pic pric­ing

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Sen. Sanders launches probe of Novo's Wegovy and Ozempic pricing